Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Online mindfulness program aims to ease chemo stress in breast cancer patients

NCT ID NCT06534957

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 30, 2026 · Updated 3 times

Summary

This study tests whether a 6-week online mindfulness program can lower stress, anxiety, and other side effects in women with breast cancer who are about to start chemotherapy. Two hundred participants will be randomly assigned to either the online mindfulness sessions or no extra support. The goal is to see if a simple, home-based program can make treatment easier to handle.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
online mindfulness-based stress reduction (MBSR)
What this could lead to
If it works, this could offer a free, home-based way to help breast cancer patients feel less stressed and manage treatment side effects.
What could go wrong
This is a small, early-stage study with no blinding, so results may be influenced by participants' expectations. The intervention is only 6 weeks long, and benefits may not last.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

128 people

The number who actually took part.

Started

Sep 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female sex * Age ≥18 years * Diagnosis of non-metastatic breast cancer * Treatment with neoadjuvant or adjuvant chemotherapy or plan to start chemotherapy in \<4 weeks * Internet access at home or in their mobile phone * Availability to participate in the online MBI for 6 weeks * Availability to answer the study surveys * Provision of signed informed consent Exclusion Criteria: * Disease recurrence * Current meditation or mindfulness practice * Inability to read or write

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Zambrano Hellion

    San Pedro Garza García, Nuevo León, 66278, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.